Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Napp Pharmaceuticals Limited
Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, CB4 0GW
Telephone: +44 (0)1223 424 444
Fax: +44 (0)1223 424 441
WWW: http://www.napp.co.uk
Medical Information Fax: +44 (0)1223 424 912

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 02/07/2010
PIL BuTrans 5, 10 and 20ug/h Transdermal Patch

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/07/2010 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 23/09/2009 and displayed until 02/07/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 03/07/2009 and displayed until 23/09/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to storage instructions
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 18/03/2009 and displayed until 03/07/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to storage instructions
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 22/05/2008 and displayed until 18/03/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 24/07/2007 and displayed until 22/05/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
  • Change to side-effects
  • Change due to user-testing of patient information
Updated on 01/09/2006 and displayed until 24/07/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 28/10/2005 and displayed until 01/09/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  buprenorphine